文献速递复苏、休克与脓毒症心脑血管急症

成人初始不可除颤心律院外心脏骤停患者自发性可除颤心律转化的预后意义:系统评价与Meta分析

Prognostic significance of spontaneous shockable rhythm conversion in adult out-of-hospital cardiac arrest patients with initial non-shockable heart rhythms: A systematic review and meta-analysis.
PubMed 文献 · Resuscitation · 2017-09-22
一句话结论初始不可除颤心律的院外心脏骤停患者若自发转化为可除颤心律,与更高的院前ROSC、1个月生存及1个月良好神经功能结局相关,但此关联取决于初始心律类型与转化时机。

该系统评价与Meta分析于2017年3月检索PubMed和EMBASE数据库,纳入12项研究、共1,108,281例初始为非可除颤心律(无脉性电活动或心搏停止)的院外心脏骤停患者。采用随机效应模型合并调整后估计值,结果显示可除颤心律转化与院前ROSC的OR=1.47(95%CI 1.40-1.55)、1个月生存的OR=1.96(95%CI 1.66-2.31)、1个月良好神经功能结局的OR=2.69(95%CI 2.00-3.62)相关,但与出院生存的OR=1.36(95%CI 0.77-2.38)无显著关联。亚组分析显示,从心搏停止(而非无脉性电活动)转化的患者与院前ROSC和出院生存相关,且较早转化者比较晚转化者与更高的1个月良好神经功能结局相关。临床意义在于,初始不可除颤心律患者出现可除颤心律转化时,可能提示预后较好,但需结合初始心律类型和转化时机综合判断。

要点

  • 在1,108,281例初始不可除颤心律的OHCA患者中,可除颤心律转化与院前ROSC的OR=1.47(95%CI 1.40-1.55)相关。
  • 可除颤心律转化与1个月生存的OR=1.96(95%CI 1.66-2.31)及1个月良好神经功能结局的OR=2.69(95%CI 2.00-3.62)相关。
  • 可除颤心律转化与出院生存的OR=1.36(95%CI 0.77-2.38)无显著关联。
  • 从心搏停止(而非无脉性电活动)转化的患者与院前ROSC和出院生存相关。
  • 较早发生可除颤心律转化者比较晚转化者与更高的1个月良好神经功能结局相关。

适用人群与场景

  • 成人院外心脏骤停患者,初始心律为不可除颤心律(无脉性电活动或心搏停止)。

研究设计与关键结果

  • 研究类型为系统评价与Meta分析,纳入12项研究,共1,108,281例初始不可除颤心律的OHCA患者,检索PubMed和EMBASE数据库(2017年3月),采用随机效应模型合并估计值。
  • 可除颤心律转化与院前ROSC的OR=1.47(95%CI 1.40-1.55)。
  • 可除颤心律转化与出院生存的OR=1.36(95%CI 0.77-2.38),无显著关联。
  • 可除颤心律转化与1个月生存的OR=1.96(95%CI 1.66-2.31),与1个月良好神经功能结局的OR=2.69(95%CI 2.00-3.62)。
  • 亚组分析:从心搏停止转化(而非无脉性电活动)与院前ROSC和出院生存相关;较早转化比较晚转化与更高的1个月良好神经功能结局相关。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,合并12项研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于初始不可除颤心律的OHCA患者,出现自发性可除颤心律转化可能提示院前ROSC、1个月生存及1个月良好神经功能结局的概率更高,但出院生存的关联无显著差异。
  • 初始心律为心搏停止者出现可除颤心律转化时,与院前ROSC和出院生存相关;初始心律为无脉性电活动者未见此关联。
  • 较早发生可除颤心律转化比较晚转化者与更高的1个月良好神经功能结局相关,提示转化时机可能影响预后判断。
  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: There remains controversy over the prognostic significance of spontaneous shockable rhythm conversion in out-of-hospital cardiac arrest (OHCA) patients with initial non-shockable heart rhythms (pulseless electrical activity [PEA] or asystole). The aim of this study was to examine the association of shockable rhythm conversion with multiple OHCA outcomes, and to explore effect modifiers.

METHODS: A dual-reviewer search was conducted in PubMed and EMBASE databases in March 2017. Data on study design, patient characteristics, outcomes, adjusting and stratifying variables were extracted. Estimates were combined using random-effects models.

RESULTS: Twelve studies involving 1,108,281 OHCA patients with initial non-shockable heart rhythms were identified using pre-specified eligibility criteria. Combined adjusted estimates showed that shockable rhythm conversion was associated with higher odds of pre-hospital return of spontaneous circulation (ROSC) (odds ratio [OR]=1.47, 95% confidence interval [CI] 1.40-1.55). Although shockable rhythm conversion was not associated with survival to hospital discharge (OR=1.36, 95% CI 0.77-2.38), it was associated with higher odds of one-month survival (OR=1.96, 95% CI 1.66-2.31), and one-month favourable neurological outcome (OR=2.69, 95% CI 2.00-3.62). Subgroup analyses found that shockable rhythm conversion from asystole, but not PEA, was associated with pre-hospital ROSC and survival to hospital discharge, and that earlier shockable rhythm conversions, compared to those occurring later during cardiopulmonary resuscitation, were associated with higher odds of one-month favourable neurological outcome.

CONCLUSION: Shockable rhythm conversion from initial non-shockable heart rhythms was associated with better OHCA outcomes, depending on the type of initial heart rhythm, and time of rhythm conversion.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Luo S, Zhang Y, Zhang W, et al. Prognostic significance of spontaneous shockable rhythm conversion in adult out-of-hospital cardiac arrest patients with initial non-shockable heart rhythms: A systematic review and meta-analysis. Resuscitation. 2017. PMID: 28943123. doi:10.1016/j.resuscitation.2017.09.014

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。